Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

Ming-Yuan Chen · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
nasopharyngeal-carcinoma
recurrent or metastatic nasopharyngeal carcinoma, nasopharyngeal carcinoma, recurrent, metastatic, pd-1 resistance, bayesian adaptive design, ivonescimab, nimotuzumab, liposomal mitoxantrone, liposomal irinotecan, s-1, interventional
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 852668
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.